Neurocognitive Outcomes in Survivors of Childhood Cancer
University of Texas, M. D. Anderson Cancer Center
All correspondence should be sent to Bartlett D. Moore, PhD, Associate Professor of Pediatrics and Neuro Oncology, Division of Pediatrics, Box 87, University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030. E-mail: bmoore{at}mdanderson.org.
Objectives To review issues associated with neurocognitive outcome in survivors of pediatric cancer. Recommendations are made for future research directions. Methods A large body of literature pertaining to neurocognitive outcome in cancer survivors was reviewed. Brain development and methodological issues that provide challenges to conducting meaningful research in cancer outcomes also are discussed. Results Neurotoxic agents used in some cancer therapies produce permanent neurocognitive sequelae, especially in very young children. Conclusions The state of neurocognitive research for pediatric cancer survivors needs to move beyond empirical studies of neurocognitive sequelae to research that will identify individual patients at risk for neurocognitive morbidity.
Key words: pediatric cancer; neurocognitive outcome; neurotoxicity.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. M. Campbell, R. T. Brown, S. E. Cavanagh, S. F. Vess, and M. J. Segall Evidence-based Assessment of Cognitive Functioning in Pediatric Psychology J. Pediatr. Psychol., October 1, 2008; 33(9): 999 - 1014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Pulte, A. Gondos, and H. Brenner Trends in 5- and 10-year Survival After Diagnosis with Childhood Hematologic Malignancies in the United States, 1990-2004 J Natl Cancer Inst, September 17, 2008; 100(18): 1301 - 1309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-M. Chen, Y.-C. Chen, and J. E. Haase Games of Lives in Surviving Childhood Brain Tumors West J Nurs Res, June 1, 2008; 30(4): 435 - 457. [Abstract] [PDF]
|
|
|
|
|
|
M. Barrera, E. Atenafu, G. S. Andrews, and F. Saunders Factors Related to Changes in Cognitive, Educational and Visual Motor Integration in Children who Undergo Hematopoietic Stem Cell Transplant J. Pediatr. Psychol., June 1, 2008; 33(5): 536 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.E. Carey, M.W. Haut, S.L. Reminger, J.J. Hutter, R. Theilmann, and K.L. Kaemingk Reduced Frontal White Matter Volume in Long-Term Childhood Leukemia Survivors: A Voxel-Based Morphometry Study AJNR Am. J. Neuroradiol., April 1, 2008; 29(4): 792 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. Daly and R. T. Brown Scholarly Literature Review: Management of Neurocognitive Late Effects with Stimulant Medication J. Pediatr. Psychol., October 1, 2007; 32(9): 1111 - 1126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Carey, M. J. Hockenberry, I. M. Moore, J. J. Hutter, K. R. Krull, A. Pasvogel, and K. L. Kaemingk Brief Report: Effect of Intravenous Methotrexate Dose and Infusion Rate on Neuropsychological Function One Year after Diagnosis of Acute Lymphoblastic Leukemia J. Pediatr. Psychol., March 1, 2007; 32(2): 189 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Spiegler, K. Kennedy, R. Maze, M. L. Greenberg, S. Weitzman, J. K. Hitzler, and P. C. Nathan Comparison of Long-Term Neurocognitive Outcomes in Young Children With Acute Lymphoblastic Leukemia Treated With Cranial Radiation or High-Dose or Very High-Dose Intravenous Methotrexate J. Clin. Oncol., August 20, 2006; 24(24): 3858 - 3864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J Wright, V. Galea, and R. D Barr Proficiency of Balance in Children and Youth Who Have Had Acute Lymphoblastic Leukemia Physical Therapy, August 1, 2005; 85(8): 782 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Patenaude and M. J. Kupst Introduction to the Special Issue: Surviving Pediatric Cancer: Research Gains and Goals J. Pediatr. Psychol., January 1, 2005; 30(1): 5 - 8. [Full Text] [PDF]
|
|